Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac (CVAC) Net Margin (2019 - 2025)

Historic Net Margin for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to 631.64%.

  • CureVac's Net Margin rose 5500200.0% to 631.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 341.99%, marking a year-over-year increase of 3086100.0%. This contributed to the annual value of 30.3% for FY2024, which is 5142600.0% up from last year.
  • Per CureVac's latest filing, its Net Margin stood at 631.64% for Q3 2025, which was up 5500200.0% from 4849.16% recorded in Q2 2025.
  • CureVac's 5-year Net Margin high stood at 5832.47% for Q1 2025, and its period low was 4849.16% during Q2 2025.
  • Over the past 5 years, CureVac's median Net Margin value was 484.5% (recorded in 2024), while the average stood at 346.31%.
  • Within the past 5 years, the most significant YoY rise in CureVac's Net Margin was 63919300bps (2025), while the steepest drop was -43646600bps (2025).
  • Over the past 5 years, CureVac's Net Margin (Quarter) stood at 13.49% in 2021, then plummeted by -8034bps to 1097.56% in 2022, then soared by 65bps to 383.77% in 2023, then plummeted by -83bps to 701.74% in 2024, then skyrocketed by 190bps to 631.64% in 2025.
  • Its Net Margin was 631.64% in Q3 2025, compared to 4849.16% in Q2 2025 and 5832.47% in Q1 2025.